Comparative Computational Research on Nanosized Molecules of SARS-CoV-2 for Validation of a Verdant Drug Molecule
- Current Science 2024
- 1173-1179
The present study assesses cubebinol from Piper cubeba as a potential antiviral against SARS-CoV-2, comparing its efficacy to remdesivir. Docking studies show that cubebinol binds more effectively to the spike proteins and papain-like protease of SARS-CoV